BindingDB logo
myBDB logout
Compile Data Set for Download or QSAR

Found 1 hit Enz. Inhib. hit(s) with Target = 'Alpha-synuclein' and Ligand = 'BDBM207911'   
Target/Host
(Institution)		LigandTarget/Host
Links		Ligand
Links		Trg + Lig
Links		Ki
nM		ΔG°
kJ/mole		IC50
nM		Kd
nM		EC50/IC50
nM		koff
s-1		kon
M-1s-1		pHTemp
°C
Alpha-synuclein


(Homo sapiens (Human))		BDBM207911
PNG
(US9266832, Cpd068)
Show SMILES COc1cccc(Cc2ccc(cc2)C(=O)NCCc2c[nH]c3ccc(Cl)cc23)c1F
Show InChI InChI=1S/C25H22ClFN2O2/c1-31-23-4-2-3-18(24(23)27)13-16-5-7-17(8-6-16)25(30)28-12-11-19-15-29-22-10-9-20(26)14-21(19)22/h2-10,14-15,29H,11-13H2,1H3,(H,28,30)
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 148n/an/an/an/a



Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent


Assay Description
α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...

US Patent US9266832 (2016)


BindingDB Entry DOI: 10.7270/Q2319TP6
More data for this
Ligand-Target Pair